ORTHOSPINE

Active

Public limited companyfounded 196858 yrs activeVaartdijk 90, 2800 Mechelen, BelgiumKBO/BCE: BE 0403.015.402

Summary

ORTHOSPINE has been active since 1968 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (€-233k) and a net result of €-95k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 5% of 4867 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (very low).

Watch Print / PDF

Checked score

Score 2025

36 / 100

Weak

The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.

Axes · tick = 2024

Profitability0=

Solvency0▼-14

Growth22=

Track record100

Bankruptcy probability, 12 months

0.5% Very low

0%0.5%1.5%4%10%≥ 25%

No credit on open account

Liquidity short (current ratio 0.66 against 0.9 in 2024; short-term debt: 150.9% and cash: 25.3% of total assets), and equity is negative.

How do we compute the score and the probability?

Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.

−lowers risk+raises risk○neutral

Long track record

A company with a long track record statistically fails less often than a young one.

KBO · incorporation date

Age against the risk zone

Annual accounts: weaker financial profile

The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.

NBB · annual accounts 2025

Solvency, return and age of the figures

Solvency

-87.1%

Return on assets

-35.5%

Age of the figures

9 mo

Lower-risk legal form

Companies with this legal form statistically fail less often than a BV.

KBO · legal form

Higher-failure-rate sector

In this sector companies fail more often than the Belgian average.

Gazette · bankruptcies per sector, NACE 46

Relative position

BE, all sectors

reference

Sector 46

higher

← fewer bankruptcies more bankruptcies →

Negative equity

The 2025 annual accounts show negative equity and a net loss.

NBB · annual accounts 2025

Equity per financial year

202122232425

2020 to 2025 · latest year €-233k

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 06-07-2026, 25 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2025

25 d early

2024

3 d early

2023

57 d late

2022

28 d late

2021

69 d early

2020

95 d early

2019

23 d early

← before the deadline after the deadline →

Checked, nothing found (2)

The next deadline is still running

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.

Companies Code · seven months

Position in the running window

24-09-2026 today31-12-2026 close31-07-2027 deadline

No strike-offs in the KBO publications

We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

KBO publications · our coverage

Financials · fiscal year 2025, full schema

Turnover

€46k▼ 97.3%

2024 · €1.73M

2020: €39.30M 2021: €48.20M 2022: €41.00M 2023: €2.77M 2024: €1.73M

2020 → 2025

EBIT margin

-189.8%▼ 165.4pp

2024 · -24.3%

2020: 5.3% 2021: -1.6% 2022: -10.8% 2023: -8.7% 2024: -24.3%

2020 → 2025

Net result

€-95k▲ 78.7%

2024 · €-446k

2020: €1.27M 2021: €-1.03M 2022: €-4.71M 2023: €-163k 2024: €-446k

2020 → 2025

Working capital

€-136k▲ 1.2%

2024 · €-138k

2020: €8.14M 2021: €6.92M 2022: €4.45M 2023: €202k 2024: €-138k

2020 → 2025

Multi-year overview

Every figure with its change against the year before

▲ rise ▼ fall

Line20212022202320242025Trend

Turnover€48.20M-€41.00M▼ 14.9%€2.77M▼ 93.2%€1.73M▼ 37.7%€46k▼ 97.3%

Equity€8.40M-€3.69M▼ 56.0%€309k▼ 91.6%€-138k€-233k▼ 69.0%

Operating result€-751k-€-4.41M▼ 487%€-240k▲ 94.6%€-420k▼ 74.9%€-88k▲ 79.2%

Net result€-1.03M-€-4.71M▼ 357%€-163k▲ 96.5%€-446k▼ 175%€-95k▲ 78.7%

Result per fiscal year

Operating resultNet result

The operating result stays negative: a loss of €88k in 2025 against €420k in 2024; the loss shrinks.

Key figures and ratios

2025 value · change against 2024

Solvency

-87.1%▼

2024 · -10.7%

Current ratio

0.66▼

2024 · 0.90

Debt to equity

-2.15▲

2024 · -10.34

ROA

-35.5%▼

2024 · -34.7%

Debt

€500k▼

2024 · €1.42M

Debt ≤ 1 year

€404k▼

2024 · €1.42M

Staff costs

€630k▼

2024 · €1.22M

Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Filed annual accounts As filed with the NBB · 2025 against 2024 · 57 lines

Balance sheet Code20242025

Assets

Total assets20/58€1.29M€267k▼

Current assets29/58€1.29M€267k▼

Stocks and contracts in progress3€144k-

Stocks30/36€144k-

Goods purchased for resale34€144k-

Amounts receivable within one year40/41€987k€197k▼

Trade receivables40€562k€197k▼

Other amounts receivable41€425k€225▼

Cash at bank and in hand54/58€156k€68k▼

Deferred charges and accrued income490/1-€3k

Equity and liabilities

Total equity and liabilities10/49€1.29M€267k▼

Equity10/15€-138k€-233k▼

Contributions10/11€574k€574k=

Capital10€574k€574k=

Issued capital100€574k€574k=

Reserves13€98k€98k=

Non-distributable reserves130/1€98k€98k=

Legal reserve130€98k€98k=

Profit (loss) carried forward14€-811k€-906k▼

Amounts payable17/49€1.42M€500k▼

Amounts payable within one year42/48€1.42M€404k▼

Trade debts44€183k€97k▼

Suppliers440/4€183k€97k▼

Taxes, remuneration and social security45€105k€297k▲

Taxes450/3€35k€232k▲

Remuneration and social security454/9€70k€66k▼

Other amounts payable47/48€1.14M€9k▼

Accrued charges and deferred income492/3-€97k

Income statement Code20242025

Operating income70/76A€3.05M€1.03M▼

Turnover70€1.73M€46k▼

Other operating income74€1.32M€983k▼

Operating charges60/66A€3.47M€1.12M▼

Goods for resale, raw materials and consumables60€1.17M€48k▼

Change in stocks: decrease (increase)609€1.17M€48k▼

Services and other goods61€842k€302k▼

Remuneration, social security and pensions62€1.22M€630k▼

Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€107k-

Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€-204k€103k▲

Other operating charges640/8€295k€1k▼

Non-recurring operating charges66A€43k€32k▼

Operating profit (loss)9901€-420k€-88k▲

Financial income75/76B€19k-

Recurring financial income75€19k-

Income from current assets751€1k-

Other financial income752/9€18k-

Financial charges65/66B€45k€8k▼

Recurring financial charges65€45k€8k▼

Debt charges650€38k€7k▼

Other financial charges652/9€7k€957▼

Profit (loss) for the period before taxes9903€-446k€-95k▲

Taxes670/3€15k-

Tax adjustments and reversals of tax provisions77€15k-

Profit (loss) for the period9904€-446k€-95k▲

Profit (loss) for the period to be appropriated9905€-446k€-95k▲

Appropriation of the result

Profit (loss) to be appropriated9906€-811k€-906k▼

Profit (loss) brought forward from the previous period14P€-364k€-811k▼

Social balance

Average headcount (FTE)908714.512.1▼

The notes to these accounts (25 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

All 46Financial 1Gazette 35Filings 10

Next filing, fiscal year 2026, expected by 31-07-2027

2026

06-07

NBB filing Annual accounts filed

fiscal year 2025 · full schema

08-01

State Gazette act Resignations: FH IMPACT MANAGEMENT BV, D&Q FINEXPERTS BV and PwC Bedrijfsrevisoren BV

Appointments: Lana Gybels, Diogo Santos de Lima and Deloitte Bedrijfsrevisoren/Réviseurs d'Entreprises BV · Director discharge · Mandate compensation17 facts ▸

General meeting, 12/12/2025
Director resignation, FH IMPACT MANAGEMENT BV (director)
Director resignation, D&Q FINEXPERTS BV (director)
Director discharge, FH IMPACT MANAGEMENT BV
Director discharge, D&Q FINEXPERTS BV
Director appointment, Lana Gybels (director)
Director appointment, Diogo Santos de Lima (director)
Mandate compensation, Lana Gybels
Mandate compensation, Diogo Santos de Lima
Power of attorney, contrast
General meeting, 24/10/2025
Director resignation, PwC Bedrijfsrevisoren BV (statutory auditor)
+5 further facts in this act

08-01

State Gazette act Capital & shares · Resignations & appointments

Power of attorney3 facts ▸

Board meeting, 16/12/2025
Power of attorney, Desiree MUTS
Power of attorney, Werner VAN ASSCHE

2025

28-07

NBB filing Annual accounts filed

fiscal year 2024 · full schema

2024

26-09

NBB filing Annual accounts filed

fiscal year 2023 · full schema · 57 days late

21-06

State Gazette act Resignations: Reinier van der List (director) and Duo-Med BidCo BV (director)

Appointments: Fh impact Management BV, D&Q Finexperts BV and Levico BV · Permanent representatives: Frédéric Hoffmann, Kristof Marivoet and Geert Kuys · Director discharge13 facts ▸

General meeting, 28/02/2024
Board meeting, 28/02/2024
Director resignation, Reinier van der List (director)
Director discharge, Reinier van der List
Director resignation, Duo-Med BidCo BV (director)
Director discharge, Duo-Med BidCo BV
Director appointment, Fh impact Management BV (director)
Permanent representative, Frédéric Hoffmann
Director appointment, D&Q Finexperts BV (director)
Permanent representative, Kristof Marivoet
Director appointment, Levico BV (day-to-day manager)
Permanent representative, Geert Kuys
+1 further facts in this act

2023

17-11

State Gazette act Appointment: Levico BV (director)

Permanent representative: Geert Kuys · Power of attorney · Modification6 facts ▸

General meeting, 07/09/2023
Board meeting, 07/09/2023
Director appointment, Levico BV (director)
Permanent representative, Geert Kuys
Power of attorney, Timothy JACOBS
Modification, website en e-mailadres geschrapt

28-08

NBB filing Annual accounts filed

fiscal year 2022 · full schema · 28 days late

31-07

State Gazette act Statutes amendment · Restructuring

Demerger · Accounting effect · Capital decrease14 facts ▸

General meeting, 12/06/2023
Demerger, Partiële splitsing: inbreng van een gedeelte van vermogensbestanddelen van Hospithera in Duomed Belgium
Accounting effect, 01/01/2023
Capital decrease, €3.925.562
Capital, €574.438
Name change, Orthospine
Purpose change, verwerking en handel in al zijn vormen ... van alle chirurgische, medische, tandheelkundige, apparatuur enz., laboratorium ... farmaceutische artikelen ... bouw…
Power of attorney, Wouter Van Cutsem
Power of attorney, Wouter Van Cutsem
Statutes amendment
Power of attorney, Olivier Kerkhofs
Power of attorney, Olivier Kerkhofs
+2 further facts in this act

09-05

State Gazette act Restructuring

Demerger · Accounting effect · Share issue5 facts ▸

Demerger, partiële splitsing door overneming
Accounting effect, 01/01/2023
Share issue, 3290, overgang van het vermogen
Power of attorney, Wouter Van Cutsem
Power of attorney, Wouter Van Cutsem

23-03

State Gazette act Restructuring · Miscellaneous

Merger2 facts ▸

Board meeting, 15/03/2023
Merger, Duomed Belgium

2022

31-12

Financial Weakest financial yearnet €-4.71M

Net result drops to €-4.71M, the lowest in the series; recovery starts the following year.

Show earlier events

07-07

State Gazette act Appointments: Deloitte Bedrijfsrevisoren BV (statutory auditor) and PwC Bedrijfsrevisoren BV (statutory auditor)

Permanent representative: Filip Lozie · Director discharge · Power of attorney6 facts ▸

General meeting, 24/06/2022
Auditor appointment, Deloitte Bedrijfsrevisoren BV
Director discharge, Deloitte Bedrijfsrevisoren BV
Auditor appointment, PwC Bedrijfsrevisoren BV
Permanent representative, Filip Lozie
Power of attorney, Wouter Van Cutsem

27-06

State Gazette act Resignations: The Surgical Company Holding B.V. (director) and Ewaldus Welteri (director)

Appointments: R.E. van der List (director) and Duo-Med BidCo B.V. (director) · Permanent representative: K. Marivoet · Mandate compensation10 facts ▸

General meeting, 25/05/2022
Board meeting, 25/05/2022
Director resignation, The Surgical Company Holding B.V. (director)
Director resignation, Ewaldus Welteri (director)
Director resignation, The Surgical Company Holding B.V. (managing director)
Director appointment, R.E. van der List (director)
Director appointment, Duo-Med BidCo B.V. (director)
Permanent representative, K. Marivoet
Mandate compensation, R.E. van der List
Mandate compensation, Duo-Med BidCo B.V.

23-05

NBB filing Annual accounts filed

fiscal year 2021 · full schema

10-01

State Gazette act Appointment: Deloitte CVBA (statutory auditor)

Permanent representatives: Luc Van Schil and Sinjoor Management B.V. · Approval7 facts ▸

General meeting, 15/04/2021
Approval, jaarrekening
Auditor appointment, Deloitte CVBA (statutory auditor)
Board meeting, 23/12/2021
Permanent representative, Luc Van Schil (permanent representative)
General meeting, 23/12/2021
Permanent representative, Sinjoor Management B.V. (permanent representative)

2021

29-09

State Gazette act Resignation: Peter de Jong (director)

Power of attorney6 facts ▸

Board meeting, 16/09/2021
General meeting, 17/09/2021
Power of attorney, Peter de Jong
Power of attorney, Timothy Jacobs
Power of attorney, Werner Van Assche
Director resignation, Peter de Jong (director)

27-04

NBB filing Annual accounts filed

fiscal year 2020 · full schema

2020

16-12

State Gazette act Registered office · Statutes amendment

Registered-office move · Statutes amendment · Capital10 facts ▸

General meeting, 2 décembre 2020
Registered-office move, 1070 Bruxelles (Anderlecht), Route de Lennik (Lenniksebaan), 451
Statutes amendment
Statutes amendment
Capital, €4.500.000
Statutes amendment
Statutes amendment
Statutes amendment
Power of attorney, Conseil d'administration
Language, Néerlandais

31-08

State Gazette act Resignation: Jan Wiliem Elemans (director)

Appointment: Ewoud Welten (director) · Power of attorney4 facts ▸

General meeting, 18/06/2020
Director resignation, Jan Wiliem Elemans (director)
Director appointment, Ewoud Welten (director)
Power of attorney, Werner Van Assche

08-07

NBB filing Annual accounts filed

fiscal year 2019 · full schema

2019

01-07

NBB filing Annual accounts filed

fiscal year 2018 · full schema

23-04

State Gazette act Appointment: Deloitte Bedrijfsrevisoren BV (statutory auditor)

Power of attorney4 facts ▸

Board meeting, 13/12/2018
Power of attorney, Peter De Jong
General meeting, 21/06/2018
Auditor appointment, Deloitte Bedrijfsrevisoren BV (statutory auditor)

2018

27-06

NBB filing Annual accounts filed

fiscal year 2017 · full schema

2017

29-11

State Gazette act Resignations & appointments

Power of attorney4 facts ▸

Board meeting, 31/10/2017
Power of attorney, Philip Van den Bogaert
Power of attorney, Peter Antonius de Jong
Power of attorney, Werner Van Assche

23-06

NBB filing Annual accounts filed

fiscal year 2016 · full schema

11-05

State Gazette act Resignations & appointments

Power of attorney · Power of attorney effective date3 facts ▸

Board meeting, 04/04/2017
Power of attorney, Philip Van Den Bogaert
Power of attorney effective date, 31/01/2017

12-04

State Gazette act Resignation: Philip Van den Bogaert (director)

Permanent representative: Sinjoor Management B.V.3 facts ▸

General meeting, 10/03/2017
Director resignation, Philip Van den Bogaert (director)
Permanent representative, Sinjoor Management B.V.

20-02

State Gazette act Resignations: Ivo D'Angelo (director) and Docpharma BVBA (director)

Appointments: The Surgical Company Holding B.V., Peter Antonius de Jong and 2 others · Permanent representatives: Sinjoor Management B.V. and Jens Neuschaefer · Director discharge19 facts ▸

General meeting, 31/01/2017
Director resignation, Ivo D'Angelo (director)
Director resignation, Docpharma BVBA (director)
Director discharge, Ivo D'Angelo
Director discharge, Docpharma BVBA
Director appointment, The Surgical Company Holding B.V. (director)
Director appointment, Peter Antonius de Jong (director)
Director appointment, Philip Van den Bogaert (director)
Director appointment, Jan Willem Elemans (director)
Mandate compensation, The Surgical Company Holding B.V.
Mandate compensation, Peter Antonius de Jong
Mandate compensation, Philip Van den Bogaert
+7 further facts in this act

2016

15-09

State Gazette act Reappointment: Docpharma SPRL (director)

Permanent representative: Jens Neuschaefer4 facts ▸

General meeting, 11/08/2016
Board meeting, 31/08/2016
Director reappointment, Docpharma SPRL (director)
Permanent representative, Jens Neuschaefer

28-01

State Gazette act Resignation: John Munson (director)

Appointments: Ivo D'Angelo (director) and Docpharma BVBA (managing director) · Mandate compensation7 facts ▸

General meeting, 21/12/2015
Board meeting, 04/01/2016
Director resignation, John Munson (director)
Director appointment, Ivo D'Angelo (director)
Mandate compensation, Ivo D'Angelo
Director appointment, Docpharma BVBA (managing director)
Mandate compensation, Docpharma BVBA

2015

17-09

State Gazette act Permanent representative: Yves Brigode

2 facts ▸

Board meeting, 31/08/2015
Permanent representative, Yves Brigode

06-08

State Gazette act Appointment: Deloitte Reviseurs d'entreprise (statutory auditor)

2 facts ▸

General meeting, 18/06/2015
Auditor appointment, Deloitte Reviseurs d'entreprise (statutory auditor)

26-02

State Gazette act Resignation: Gary Sphar (director)

Appointment: John Munson (director) · Mandate compensation4 facts ▸

General meeting, 31/12/2014
Director resignation, Gary Sphar (director)
Director appointment, John Munson (director)
Mandate compensation, John Munson

2014

14-08

State Gazette act Capital & shares · Statutes amendment

Capital increase · Capital decrease · Capital6 facts ▸

General meeting, 17/07/2014
Capital increase, €3.000.000
Capital decrease, €3.000.000
Capital, €4.500.000
Reserve release, 56.325,01, 1.905.245,80
Statutes amendment

03-03

State Gazette act Purpose · Statutes amendment

Purpose change2 facts ▸

General meeting, 30/12/2013
Purpose change, La société a pour objet, soit pour elle-même, soit pour compte des tiers, soit en participation, en Belgique ou à l'étranger, -de faire la transformation et le…

13-01

State Gazette act Permanent representative: Khadija Badli

2 facts ▸

Board meeting, 17/12/2013
Permanent representative, Khadija Badli

2013

11-10

State Gazette act Permanent representatives: Pascale Engelen and Mylan SPRL

3 facts ▸

Board meeting, 24/09/2013
Permanent representative, Pascale Engelen
Permanent representative, Mylan SPRL

04-02

State Gazette act Permanent representative: Pascale Engelen

2 facts ▸

General meeting, 04/01/2013
Permanent representative, Pascale Engelen

2012

30-11

State Gazette act Resignation: Patrick Vink (director)

Appointment: Gary Elmer Sphar (director) · Director discharge4 facts ▸

General meeting, 05/11/2012
Director resignation, Patrick Vink (director)
Director discharge, Patrick Vink
Director appointment, Gary Elmer Sphar (director)

23-07

State Gazette act Appointment: Deloitte Reviseurs d'entreprise (statutory auditor)

3 facts ▸

Board meeting, 05/06/2012
General meeting, 21/06/2012
Auditor appointment, Deloitte Reviseurs d'entreprise (statutory auditor)

2011

29-04

State Gazette act Resignation: Seshan Srinivasan (director)

Appointment: Patrick Vink (director) · Mandate compensation4 facts ▸

General meeting, 12-04-2011
Director resignation, Seshan Srinivasan (director)
Director appointment, Patrick Vink (director)
Mandate compensation, Patrick Vink

2010

05-10

State Gazette act Reappointment: Docpharma SPRL (director)

Mandate compensation3 facts ▸

General meeting, 17/06/2010
Director reappointment, Docpharma SPRL (director)
Mandate compensation, Docpharma SPRL

02-03

State Gazette act Statutes amendment

Accounting effect · Fiscal-year end · Financial year duration7 facts ▸

General meeting, 28/12/2009
Statutes amendment
Accounting effect, 01/04/2009
General-meeting date, 3rd Thursday of June at 16:00
Fiscal-year end, 31 December
Fiscal-year end, 31/12/2009
Financial year duration, 9 months

2009

02-03

State Gazette act Capital & shares · Statutes amendment · Resignations & appointments

Capital increase · Capital decrease · Capital9 facts ▸

General meeting, 10/02/2009
Capital increase, €1.800.000
Capital decrease, €1.800.000
Capital, €4.500.000
Statutes amendment
Power of attorney, NautaDutilh
Power of attorney, Chambre de Commerce et de l'Industrie de Bruxelles ASBL
Power of attorney, Conseil d'administration
Power of attorney, Gérard INDEKEU

2005

12-01

State Gazette act Capital & shares · Statutes amendment

Statutes amendment · Accounting effect · Capital9 facts ▸

General meeting, 16/12/2004
Statutes amendment
Statutes amendment
Accounting effect, 01/01/2004
Statutes amendment
Capital, €4.500.000
Power of attorney, Manoel Dekeyser
Power of attorney, Xavier Van Cauter
Power of attorney, J.Jordens

Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors

9 directors, no change since 2025

Diogo Santos de Lima

Director · since 12-12-2025

Current

Lana Gybels

Director · since 12-12-2025

Current

LEVICO

Day-to-day manager · since 07-09-2023 · Private limited company · perm. rep.: Geert Kuys

Current

Duo-Med BidCo B.V.

Director · since 25-05-2022 · Legal entity · perm. rep.: K. Marivoet

Current

R.E. van der List

Director · since 25-05-2022

Current

Ewoud Welten

Director · since 18-06-2020

Not recently confirmed

3 other directors

Jan Willem Elemans

Director · since 31-01-2017

Not recently confirmed

Docpharma SPRL

Director · since 11-08-2016 · Legal entity · perm. rep.: Jens Neuschaefer

Not recently confirmed

Gary Elmer Sphar

Director · since 05-11-2012

Not recently confirmed

12-12-2025 Diogo Santos de Lima: Appointed as Director

12-12-2025 Lana Gybels: Appointed as Director

12-12-2025 D&Q FINEXPERTS: Resigned as Director

12-12-2025 FH IMPACT MANAGEMENT: Resigned as Director

28-02-2024 LEVICO: Appointed as Day-to-day manager

Full history in the Timeline (39 changes) →

Location & real-estate footprint

Registered office, Mechelen · 1 establishment unit since 2014

establishment The establishment unit on the map

Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Vaartdijk 902800 Mechelen

Ground area

6.7 ha

Building footprint

2.2 ha

Volume, LiDAR

204,601 m³

2 parcels, Flanders, Wallonia · tallest building 21.6 m, ±4 floors. Linked by address, not a title deed.

1 establishment unit

Hospithera

Rue de l'Industrie 30c, 1400 NivellesWholesale of pharmaceutical and medical goods

since 20142.236.070.130

2 parcels

Flanders 1 (50%) Wallonia 1 (50%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
25099D0027/00W000	Wallonia	6.1 ha	1 · 1.9 ha	13.9 m · 3 fl.
12403D0040/00W004 ProtectedMonumentBurgerhuis ontworpen door Jef HuyghSource ↗	Flanders	5,413 m²	1 · 2,703 m²	21.6 m · 4 fl.

Linked by address, not proof of ownership

Methodology

via registered seat: 1 · via establishment units: 1

2 of 2 parcels with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

1 of these parcels carry protected heritage (source: regional heritage registers, Onroerend Erfgoed / patrimoine.brussels).

Statutory auditor

1 auditor

Deloitte Bedrijfsrevisoren/Réviseurs d'Entreprises BVCurrent

Statutory auditor

08-01-2026 → present

Show 4 earlier auditors

BV PwC Bedrijfsrevisoren Auditor · represented by Filip Lozie	07-07-2022 → 30-06-2025
CVBA Deloitte Statutory auditor · represented by Gert Vanhees succeeded by Deloitte Bedrijfsrevisoren/Réviseurs d'Entreprises BV in 2026	10-01-2022 → 08-01-2026
DELOITTE Bedrijfsrevisoren BV Auditor succeeded by CVBA Deloitte in 2022	23-04-2019 → 10-01-2022
Deloitte Bedrijfsrevisoren/Réviseurs d’Entreprises Statutory auditor succeeded by DELOITTE Bedrijfsrevisoren BV in 2019	23-07-2012 → 23-04-2019

Articles of association

Purpose

De vennootschap heeft de uitoefening van de volgende verrichtingen tot voorwerp, zowel in België als in het buitenland, voor eigen rekening, voor rekening van derden of in…

Full purpose

De vennootschap heeft de uitoefening van de volgende verrichtingen tot voorwerp, zowel in België als in het buitenland, voor eigen rekening, voor rekening van derden of in samenwerking met derden: - verwerking en handel in al zijn vormen (aankoop, verkoop, invoer uitvoer, exploitatie van octrooien, licenties en andere zaken effecten, makelaardij, enz.) van alle chirurgische, medische, tandheelkundige, apparatuur enz., laboratorium in welke vorm dan ook, van farmaceutische artikelen, alle artikelen van parfumerieën, toiletartikelen, levensmiddelen, dieetproducten of niet, van alle chemische producten, producten en artikelen die direct of indirect betrekking hebben tot de geneeskunst, evenals alle artikelen, in verband met de industrie in het algemeen; - de aankoop, groot- en kleinhandel, import en export van alle bouwmaterialen, bouwapparatuur en elektrische en sanitaire voorzieningen, alsmede alle accessoires en apparatuur die nuttig zijn voor de voltooiing van bouwwerkzaamheden of werkzaamheden aan delen van bouwwerkzaamheden, zowel als hoofdaannemer als onderaannemer, van bovengenoemde producten met gebruikmaking van alle technieken en eventuele grondstoffen. Zij kan zowel in België als in het buitenland alle financiële, industriële, commerciële, roerende of onroerende verrichtingen uitvoeren die rechtstreeks of onrechtstreeks verband houden met haar maatschappelijk doel en die haar in staat stellen haar doelstellingen te verwezenlijken. Zij kan belangen nemen door associatie, inbreng, fusie, financiële tussenkomst of op gelijk welke andere wijze, in alle vennootschappen, verenigingen of ondernemingen met een identiek, gelijklopend of samenhangend voorwerp met het hare of die van aard kunnen zijn de ontwikkeling van haar onderneming te begunstigen of een bron van afzetten te vormen. De vennootschap mag zich borgstellen of zakelijke zekerheden verlenen ten voordele van vennootschappen of particulieren, in de meest ruime zin. Deze opsomming is niet-limitatief en moet in de breedste zin van het woord worden geïnterpreted.

according to the deed of 16-12-2020

Structure & network

Connections & network

4 connected companies

Shared directors

Linked via shared directors

GS1

Shared director

→

AKTUAPHARMA

Shared corporate director

→

DUOMED BELGIUM

Shared corporate director

→

Duomed Holding Benelux

Shared corporate director

→

Acquisitions and mergers

2 transactions

Taken over by:Duomed Belgium

BE 0416.834.437proposal · State Gazette act of 14-04-2023 (2 acts)

Split off to:Duomed Belgium

BE 0416.834.437partial demerger · State Gazette act of 31-07-2023 (3 acts)

Capital and shareholders

Capital over the years

31-07-2023 Capital reduction of 3,925,562 EUR · in a demerger
16-12-2020 Capital stated in the act · 4,500,000 EUR · 64,167 shares
14-08-2014 Capital increase of 3,000,000 EUR · to 7,500,000 EUR · 25,667 new shares
14-08-2014 Capital reduction of 3,000,000 EUR · to 4,500,000 EUR · to absorb losses
02-03-2009 Capital increase of 1,800,000 EUR · to 6,300,000 EUR · 11,000 new shares · in kind
02-03-2009 Capital reduction of 1,800,000 EUR · to 4,500,000 EUR · to absorb losses
12-01-2005 Capital stated in the act · 4,500,000 EUR

Similar companies · same sector, comparable size

VANDEPUTTE MEDICAL

BE 0839.310.910

Antwerpen · Eq €308,460

Remicourt · Eq €309,862

MEGA-MOBILITY

BE 0738.831.479

Beringen · Eq €305,277

Of 1,898 companies in sector 46460 we hold annual accounts for 1,116. 734 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company data · Crossroads Bank

Identification

Legal formPublic limited company

Founded01-01-1968

Fiscal year end31-12

Activities, NACEBEL 2025

46460Wholesale of pharmaceutical and medical goods

Sources

Crossroads Bank for EnterprisesNational Bank · 50 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.

Contact details

3 entries

Website:www.hospithera.com

Enterprise

E-mail:info@hospithera.com

Enterprise

E-mail:info@tsc-be.com

Enterprise